Linked Life Data

16778446

Source:http://linkedlifedata.com/resource/pubmed/id/16778446

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-6-16
pubmed:abstractText
The important epidemiological relevance of the overactive bladder (OAB) syndrome and its impact on the quality of life of sufferers have increased research both in basic science and in clinical fields, with the pharmacological treatment of OAB syndrome being particularly investigated. Recently a new perspective for the use of alpha-adrenolytic drugs in the treatment of OAB syndrome has been gained due to encouraging anecdotal data and to the identification of different adrenoceptor subtypes in the female lower urinary tract. Starting with a survey of female lower urinary tract disorders, the authors review the present pharmacological treatment of these disorders and delineate the new perspectives acquired from recent studies of adrenoceptor subtypes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1018-8843
pubmed:author
pubmed:copyrightInfo
2006 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
83-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives.
pubmed:affiliation
Clinica Ostetrica e Ginecologica, Insubria University, Varese, Italy. stefanosalvatore@hotmail.com
pubmed:publicationType
Journal Article, Comparative Study, Review